Wyndgate Technologies(R) Delivers Electronic Blood Bank System to St. John's Medical Center
April 25 2006 - 10:00AM
PR Newswire (US)
DENVER, April 25 /PRNewswire-FirstCall/ -- Wyndgate
Technologies(R), a division of Global Med Technologies(R) Inc.,
(OTC:GLOB) (BULLETIN BOARD: GLOB) announced today that St. John's
Medical Center has purchased its SafeTrace Tx(R)* advanced
transfusion management system. Terms of the agreement were not
disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) St.
John's Medical Center will be moving to an automated blood bank
with Wyndgate's SafeTrace Tx solution. The installation of this
system will allow the blood bank to streamline information from the
hospital's laboratory and other electronic record systems as well
as input and track its own data. Blood bank employees will be able
to track specimens and test results more easily and quickly with
the new system. Blood Bank Supervisor Judy Lewis, MT, SBB(ASCP),
voiced her enthusiasm about the system saying, "We are very excited
to have SafeTrace Tx in our laboratory. We have been operating with
a manual paper system, which was cumbersome and time-consuming.
SafeTrace Tx will improve our record keeping with less time
involved. The Patient-At-A-Glance Bar(TM) is a great feature for
patient history review and current specimen expiration time. We
believe SafeTrace Tx has many safety features that will help St.
John's." The ability of SafeTrace Tx to interface with the other
computerized systems at St. John's was a key element in its
purchase because it ensures that the medical center may continue
building its network and improving access to information. "Another
consideration in St. John's choosing SafeTrace Tx is Wyndgate's
partnership with our current HIS vendor. This partnership is
important to our medical center for future integration," stated
Redeem Sumicad, MBA, MLT(ASCP), Administrative Director of the
Laboratory at St. John's. "More and more blood banks are choosing
to go to electronic software systems to take advantage of faster,
easier, and more thorough specimen management," commented Wm. Scott
Dustin, Vice President of Sales and Marketing. "We are pleased to
be able to help St. John's Medical Center realize these benefits
and maintain their high standards for safety. We look forward to
working with St. John's and their new system." About St. John's
Medical Center St. John's Medical Center is a fully-accredited
medical center and long-term care facility in Jackson Hole,
Wyoming. The medical center serves the needs of Teton and
surrounding counties. St. John's Medical Center boasts a
state-of-the-art Clinical Laboratory and Diagnostics Imaging
facilities. About Global Med Technologies, Inc. Global Med
Technologies, Inc. is an international e-Health, medical
information technology company, providing information management
software products and services to the healthcare industry. Its
Wyndgate Technologies division is a leading supplier of information
management systems to U.S. and international blood centers and
hospital transfusion centers. Current clients of Wyndgate's
products and services manage more than 3 million units of blood, or
over 22% of the U.S. blood supply, each year. Wyndgate's products
are being used in Canada and sub-Saharan Africa, and are being
implemented in the Caribbean. Together, the SafeTrace Tx(R)
advanced transfusion management system and the SafeTrace(R) donor
management system provide Vein-to-Vein(R) tracking from donor
collection to patient transfusion. For more information about
Global Med's products and services, please call 800-WYNDGATE or
visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release. * Patent Pending
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies,
Inc., +1-303-238-2000; or Investor Relations, Paul Short, President
of Investment Strategies, LLC, +1-304-523-3252, for Global Med
Technologies Inc. Web site: http://www.globalmedtech.com/
http://www.wyndgate.com/
Copyright